[1]魏 威,梁凯轶,余艳芳,等.血嗜酸性粒细胞在肺结节良恶性判断中的价值[J].医学信息,2022,35(03):99-102.[doi:10.3969/j.issn.1006-1959.2022.03.023]
 WEI Wei,LIANG Kai-yi,YU Yan-fang,et al.Value of Blood Eosinophils in the Diagnosis of Benign and Malignant Pulmonary Nodules[J].Medical Information,2022,35(03):99-102.[doi:10.3969/j.issn.1006-1959.2022.03.023]
点击复制

血嗜酸性粒细胞在肺结节良恶性判断中的价值()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年03期
页码:
99-102
栏目:
论著
出版日期:
2022-02-01

文章信息/Info

Title:
Value of Blood Eosinophils in the Diagnosis of Benign and Malignant Pulmonary Nodules
文章编号:
1006-1959(2022)03-0099-04
作者:
魏 威1梁凯轶2余艳芳1屠春林1赵开顺1周 慧2
上海健康医学院附属嘉定区中心医院呼吸与危重症医学科1,放射科2,上海 201800
Author(s):
WEI Wei1LIANG Kai-yi2YU Yan-fang1TU Chun-lin1ZHAO Kai-shun1ZHOU Hui2
Department of Respiratory Medicine1,Department of Radiology2,Jiading District Central Hospital Affiliated Shanghai Universityof Medicine & Health Sciences,Shanghai 201800,China
关键词:
肺结节血嗜酸性粒细胞良恶性诊断
Keywords:
Pulmonary nodulesBlood eosinophilsBenign and malignant diagnosis
分类号:
R816.4
DOI:
10.3969/j.issn.1006-1959.2022.03.023
文献标志码:
A
摘要:
目的 探讨血嗜酸性粒细胞对肺结节良恶性鉴别的诊断价值。方法 选择2017年1月-2019年12月在我院行胸部CT提示为肺结节,并经穿刺活检明确病理诊断的患者72例为研究对象;依据病理诊断分为恶性组43例,非恶性组29例,收集两组患者的临床资料并比较,包括年龄、血白细胞、血小板、血中性粒细胞、血淋巴细胞、血单核细胞、血白蛋白、血嗜酸性粒细胞、血嗜碱性粒细胞、血NLR、血总胆红素、血CEA、血CYFRA211、NSE、SCC-Ag,对恶性肺结节的危险因素进行单因素和多因素Logistic回归分析。结果 两组血小板、血嗜酸性粒细胞、血CEA、血CYFRA211、血NSE比较,差异有统计学意义(P<0.05);两组年龄、血白细胞、中性粒细胞、淋巴细胞、单核细胞、血清白蛋白、血NLR、血总胆红素、SCC-Ag比较,差异无统计学意义(P>0.05);多因素Logistic回归分析表明,血嗜酸性粒细胞是恶性肺结节的独立危险因素。结论 血嗜酸性粒细胞表达水平升高是诊断恶性肺结节的独立危险因素,对判断肺部结节的良恶性有重要的价值。
Abstract:
Objective To investigate the value of blood eosinophils in the diagnosis of benign and malignant pulmonary nodules.Methods From January 2017 to December 2019, 72 patients with pulmonary nodules diagnosed by chest CT and confirmed by biopsy were selected as subjects. According to the pathological diagnosis, the patients were divided into malignant group (43 cases) and non-malignant group (29 cases). The clinical data of the two groups were collected and compared, including age, white blood cells, platelets, blood neutrophils, blood lymphocytes, blood monocytes, serum albumin, blood eosinophils, blood basophils, blood NLR, blood total bilirubin, blood CEA, blood CYFRA211, NSE and SCC-Ag. The risk factors of malignant pulmonary nodules were analyzed by univariate and multivariate Logistic regression analysis.Results The differences in platelet, blood eosinophils, serum CEA, serum CYFRA211 and serum NSE between the two groups were statistically significant (P<0.05). There was no significant difference in age, white blood cells, neutrophils, lymphocytes, monocytes, serum albumin, blood NLR, total bilirubin and SCC-Ag between the two groups (P>0.05). Multivariate Logistic regression analysis showed that blood eosinophils were independent risk factors for malignant pulmonary nodules.Conclusion Elevated blood eosinophil expression is an independent risk factor for the diagnosis of malignant pulmonary nodules, which has important value in judging benign and malignant pulmonary nodules.

参考文献/References:

[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[2]中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺部结节诊治中国专家共识[J].中华结核和呼吸杂志,2015,38(4):249-254.[3]Detterbeck FC,Boffa DJ,Kim AW,et al.The eighth edition lung cancer stage classification[J].Chest,2017,151(1):193-203.[4]周清华,范亚光,王颖.中国肺部结节分类、诊断与治疗指南(2016年版)[J]中国肺癌杂志,2016,19(12):793-798.[5]余翔,张敏,刘建光.孤立性肺结节影像学特征的logistic回归分析[J].蚌埠医学院学报,2019,44(7):936-939.[6]Macmahon H,Naidich DP,Goo JM,et al.Guidelines for management of incidental pulmonary nodules detected on CT images:from the Fleischner ociety 2017[J].Radiology,2017,284(1):228-243.[7]Varoli F,Vergani C,Caminiti R,et al.Management of solitary pulmonary nodule[J].Ear J Cardiothorae Surg,2008,33(3):461-465.[8]刘慧,李永怀,桂淑玉.肺癌患者血清肿瘤标记物检测的临床意义及预后评估[J].临床肺科杂志,2014,19(12):2219-2222.[9]Chu XY,Hou XB,Song WA,et al.Diagnostic values of SCC, CEA,Cyfra21-1 and NSE for lung Cancer in patients with suspicious pulmonary:a single center analysis[J].Cancer Biol Ther,2011,11(12):995-1000.[10]Horinouchi H.Anti-vascular endothelial growth factor therapies at the crossroads:linifanib for non-small cell lung cancer[J].Trans1 Lung Cancer Res,2016,5(1):78-81.[11]马进林,马晓艳,王海强.肺癌孤立性肺结节患者64排螺旋CT扫描影像特点分析[J].中华肺部疾病杂志(电子版),2021,14(1):48-52.[12]Cho A,Hur J,Moon YW,et al.Correlation between EGFR gene mutation.cytologic tumor markers.18F-FDG uptake in non-small cell lung cancer[J].BMC Cancer,2016(16):224-232.[13]李艳萍,殷俊.血清肿瘤标志物与肺癌高危因素的临床分析[J].中华肺部疾病杂志(电子版),2017,10(3):321-324.[14]李笑莹,刘芳,车海杰,等.肿瘤标志物预测孤立性肺结节恶性概率模型的建立与初步评价[J].山东大学学报,2017,55(4):60-64.[15]雷晴,彭波,龙飞,等.孤立性肺结节与肿瘤标记物动态水平的相关性研究[J].四川医学,2016,37(6):588-591.[16]李四香,李镭,杨茗,等.肺癌患者血常规指标特征分析[J].华西医学,2020,35(9):1060-1067.[17]Hanahan D,Weinberg RA.Hallmarks of cancer: the next generation[J].Cell,2011,144(5):646-674.[18]Fulkerson PC.Transcription Factors in Eosinophil Development and As Therapeutic Targets.Front Med (Lausanne),2017(4):115.[19]Weller PF,Spencer LA.Functions of tissue-resident eosinophils[J].Nat Rev Immunol,2017,17(12):746-760.

相似文献/References:

[1]张铁彪,刘建华,马长顺.肺癌肿瘤标记物结合胸部CT检查肺结节的定性分析[J].医学信息,2022,35(10):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
 ZHANG Tie-biao,LIU Jian-hua,MA Chang-shun.Qualitative Analysis of Lung Cancer Tumor Markers Combined with Chest CT Examination of Pulmonary Nodules[J].Medical Information,2022,35(03):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
[2]韦能宝,薛志刚,毕金文.尿源性脓毒血症诊治分析[J].医学信息,2018,31(24):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
 WEI Neng-bao,XUE Zhi-gang,BI Jin-wen.Diagnosis and Treatment of Urinary Sepsis[J].Medical Information,2018,31(03):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
[3]邓燕云,覃丽兰,黄晓琪.PET/CT功能影像引导肺部结节性病变穿刺活检的研究进展[J].医学信息,2022,35(14):147.[doi:10.3969/j.issn.1006-1959.2022.14.038]
 DENG Yan-yun,QIN Li-lan,HUANG Xiao-qi.Research Progress of PET/CT Functional Imaging Guided Biopsy of Pulmonary Nodular Lesions[J].Medical Information,2022,35(03):147.[doi:10.3969/j.issn.1006-1959.2022.14.038]
[4]张 蕊,任 徽.CT引导下经皮肺穿刺活检术诊断肺占位病变的研究[J].医学信息,2019,32(17):97.[doi:10.3969/j.issn.1006-1959.2019.17.030]
 ZHANG Rui,REN Hui.The Value of CT-guided Percutaneous Lung Biopsy in the Diagnosis of Pulmonary Space-occupying Lesions[J].Medical Information,2019,32(03):97.[doi:10.3969/j.issn.1006-1959.2019.17.030]
[5]徐涑珅,石昌国,张晓伟.同期与分期肺结节手术对双侧肺结节患者术后肺功能及血气指标的影响[J].医学信息,2022,35(04):137.[doi:10.3969/j.issn.1006-1959.2022.04.035]
 XU Su-shen,SHI Chang-guo,ZHANG Xiao-wei.Effects of Simultaneous and Staged Pulmonary Nodule Surgery on Postoperative Pulmonary Function and Blood Gas Indexes in Patients with Bilateral Pulmonary Nodules[J].Medical Information,2022,35(03):137.[doi:10.3969/j.issn.1006-1959.2022.04.035]
[6]周国华,李建伟,沈海平,等.基于BMI的正位定位像技术在个性化低剂量CT肺结节筛查中应用价值[J].医学信息,2025,38(18):42.[doi:10.3969/j.issn.1006-1959.2025.18.009]
 ZHOU Guohua,LI Jianwei,SHEN Haiping,et al.Application Value of BMI-based Anteroposterior Positioning Technologyin Personalized Low-dose CT Screening for Lung Nodule[J].Medical Information,2025,38(03):42.[doi:10.3969/j.issn.1006-1959.2025.18.009]

更新日期/Last Update: 1900-01-01